Physicochemical properties of lomefloxacin, levofloxacin, and moxifloxacin relevant to the Biopharmaceutics Classification System

Acta Chimica Slovenica

Volumn 61, Issue 4, 2014, Pages 827-834

  Ska Szmurło, Ewa Kłosiń ^a   Grudzień, Monika ^b   Betlejewska Kielak, Katarzyna ^a,b   Pluciński, Franciszek ^b   Biernacka, Joanna ^a   Mazurek, Aleksander Paweł ^a,b  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b NATIONAL MEDICINES INSTITUTE   (Poland)

Author keywords

BCS; Bioavailability; Fluoroquinolones; Molecular modeling

Indexed keywords

ANTIINFECTIVE AGENT; LEVOFLOXACIN; LOMEFLOXACIN; MOXIFLOXACIN; PHOSPHATE; PROTON; QUINOLONE DERIVATIVE; SOLVENT;

CHEMICAL STRUCTURE; CHEMISTRY; CONFORMATION; DRUG EFFECTS; ELECTROCHEMISTRY; GASTROINTESTINAL TRACT; HUMAN; MEDICINAL CHEMISTRY; PERMEABILITY; PH; PHARMACEUTICS; POTENTIOMETRY; PROCEDURES; QUANTUM THEORY; SOLUBILITY; STATIC ELECTRICITY; TEMPERATURE;

ANTI-BACTERIAL AGENTS; BIOPHARMACEUTICS; CHEMISTRY, PHARMACEUTICAL; ELECTROCHEMISTRY; FLUOROQUINOLONES; GASTROINTESTINAL TRACT; HUMANS; HYDROGEN-ION CONCENTRATION; LEVOFLOXACIN; MODELS, MOLECULAR; MOLECULAR CONFORMATION; PERMEABILITY; PHOSPHATES; POTENTIOMETRY; PROTONS; QUANTUM THEORY; SOLUBILITY; SOLVENTS; STATIC ELECTRICITY; TEMPERATURE;

EID: 84921663531     PISSN: 13180207     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. FDA. The Biopharmaceutical Classification System (BCS) Guidance Office of Pharmaceutical Science. CDER 2006.
2. Cozzini P., Spyrakis F., Hydrophobicity in Drug Design. Exercise 12, 2006, University of Parma.
3. Appelbaum P. C., Hunter P. A., Int. J. of Antimicrobial Agents 2000, 1, 5-15.
4. Andriole VT., Formulary 2002, 3, 13-15.
5. Rubinstein E., Chemotherapy 2001, 3, 3-8.
6. th ed, New York 2005.
7. McGregor J. C., Allen G. P., Bearden D. T., Ther. Clin. Risk Manag. 2008, 5, 843-853.
8. Liu H., Mulholland S. G., Am. J. Med. 2005, 7, 14S-20S.
9. European Medicines Agency recommends restricting the use of oral moxifloxacin-containing medicines http://www.ema. europa.eu/docs/en-GB/document-library/Press-release/ 2010/08/WC500095423.pdf
10. Sun J., Sakaia S., Tauchia Y., Deguchia Y., Chenb J., Zhangb R., Morimoto K., Eur. J. Pharm. Biopharm. 2002, 54, 51-58.
11. Takacs-Novak K., Noszál B., Hermecz I., Keresztúri G., Podányi B., Szász G., J. Pharm. Sci. 1990, 79, 1023-1028.
12. Langlois M. H., Montagut M., Dubost J. P., Grellet J., Saux M. C., J. Pharm. Biomed. Analysis 2005, 37, 389-393.
13. Volgyi G., Vizserálek G., Takács-Novák K., Avdeef A., Tam K.Y., Eur. J. Pharm. Sci. 2012, 47, 21-27.
14. OECD, Paris, 1981, Test Guideline 107, Decision of the Council C(81) 30 final.
15. Box K., Anal. Chem. 2003, 75, 883-892.
16. Liu X., Testa B., Fahr A., Pharm. Res. 2011, 28, 962-977.
17. Vazquez J. L., Merinoa S., Domìnecha Ò., Berlangab M., Viñasb M., Monteroa M. T., Hernández-Borrell J., Int. J. Pharm. Sci. 2001, 220, 53-62.
18. Takacs-Novak K., Józan M., Hermecz I., Szász G., Int. J. Pharm. 1992, 79, 89-96.
19. Halgren T.A., J. Computational Chem. 1996, 17, 490.
20. Hehre W. J., A Guide to Molecular Mechanics and Quantum Chemical Calculations, Wavefunction, Inc., Irvine, CA, 2003.
21. Tetko I. V., Tanchuk V. Y., J. Chem. Inf. Comput. Sci. 2002, 42, 1136-1145.
22. Rekker R. F., Pharmacochemistry Library, Elsevier, NY, 1977, vol 1.
23. Mannhold R., Lipophilicity: Its calculation and application in ADMET predictions, Molecular Drug Research Group, Germany 2006, Solvay Pharmaceuticals Conferences.
24. Mannhold R., Poda G. I., Ostermann C., Tetko I. V., J. Pharm. Sci. 2009, 3, 861-893.
25. Interactive logP calculator http://www.molinspiration.com/ services/logp.html.
26. Hansch C., Leo A., Hoekman D., Hydrophobic, Electronic, and Steric Constants. ed., 1995, Washington, DC: American Chemical Society pp. 368.
27. Furet Y. X., Deshusses J., Pechere J. C., Antimicrob. Agents Chemother. 1992, 36, 2506-2511.
28. Cramariuc O., Biochim. Biophys. Acta 2012, 1818, 2563-2571.
29. th Report, Geneva 2006.
30. Petrauskas A. A., Kolovanov E. A., Perspect. Drug Discov. 2000, 19, 99-116.
31. Choi S. H., Kim E. Y., Kim Y. J., Kor. J Pediatr. 2013, 5, 196-201.
32. Maurer N., Wong K. F., Hope M. J., Cullis P. R., Biochem. Biophys. Acta 1998, 1374, 9-20.
33. Vazquez J. L., Montero T. M., Merino S., Domènech Ò., Berlanga M., Viñas M., and Hernández-Borrell J., Langmuir 2001, 17, 1009-1014.
34. Hancock R. E. W., Raffle J., Nicas T. I., Antimicrob. Agents Chemother. 1981, 19, 777-785.
35. Neves P., Leite A., Rangel M., de Castro B., Gameiro P., Anal. Bioanal. Chem. 2007, 387, 1543-1552.
36. Volpe D. A., J. Pharm. Sci. 2004, 2, 1-6.